MENU

Changelog

2020

[01-27-20] - Added Pantoprazole as per DM No. 2020-0018 : { p.36}

2019

[11-21-19] - Deleted Chlorpromazine 50 mg tablet (as hydrochloride) and 25 mg/mL (as hydrochloride), 1 mL ampule (IM, IV) based on this Document : { p.9}

[11-21-19] - Deleted Heparin 1000 IU/mL and 5000 IU/mL, 30 mL vial (IV infusion, SC) (bovine origin) based on this Document : { p.22}

[08-30-19] - Deleted Conjugated Equine Estrogen (dual entry): { p.11 }

[08-30-19] - Deleted 7‐ valent suspension, pre‐filled syringe (IM) in Pneumoccocal Conjugate Vaccine : { p.37 }

[08-05-19] - Clarification on the specification of Levothyroxine in the Philippine National Formulary as per DM No. 2019-0294 : { p.23 }

[07-23-19] - Added Hypertonic lactate solution as per DM No. 2019-0287 : { p.23 }

[07-23-19] - Added Iodixanol as per DM No. 2019-0287 : 652 mg/mL (equivalent to 320 mg iodine) solution for injection, 50 mL and 100 mL vial and 550 mg/mL (equivalent to 270 mg iodine) solution for injection, 50 mL vial : { p.24 }

[07-05-19] - Revision in the specifications of Famotidine as per DM No. 2019-0286 : Changed from 10 mg/mL, 2 mL ampule/vial (IM, IV) to 20 mg powder/lyophilized powder for injection, ampule/vial : { p.18}

[07-05-19] - Added Bedaquiline fumarate as per DM No. 2019-0250 : 100 mg tablet : { p.5 }

[07-05-19] - Added Delamanid as per DM No. 2019-0250 : 50 mg film-coated tablet : { p.12 }

[07-05-19] - Added Polymixin B sulfate as per DM No. 2019-0250 : 500,000 Units powder for solution for injection (Intrathecal/IM/TV), 5 mL vial : { p.37 }

[07-05-19] - Added Levobupivacaine as per DM No. 2019-0250 : 5 mg/mL solution for injection, 10 mL ampule : { p.27 }

[07-05-19] - Revision in the specifications of Epinephrine as per DM No. 2019-0251 : Changed from 1 mg/mL, 1 mL ampule (IM, SC) to 1 mg/mL, 1 mL ampule (IV, IM, SC) : { p.17}

[06-11-19] - Added Neostigmine (Re-inclusion, as per DM No. 2019-0206) : 500 mcg/mL solution for injection (IM/IV/SC), 1 mL ampule : { p.32 }

[06-04-19] - Revision in the specifications of multivitamins and amino acid solutions for infants in the Philippine National Formulary, as per DM No. 2019-0196 :

[Multivitamins] Vitamin D for infants (per 1 mL drops) and Children (per 5 mL syrup) changed from (200 IU (5 mcg)) to (200-400 IU (5-10 mcg)) ; Vitamin C for adult (per tablet/capsule) changed from (65 - 80 mg) to (60 - 80 mg) : { p.31-30}

[Amino Acid Solutions for infants] Protein changed from (20 - 50 g including taurine) to (5 - 10 g including taurine) ; Calories changed from (80 - 150 kcal) to (20 - 40 kcal) { p.2}

[01-04-19] - Clarification on the specifications of lactulose in the Philippine National Formulary, as per DM No. 2019-0150 : changed from 3.3 g/5 mL syrup to 3.3 g/5 mL (3.35 g/5 mL) syrup : { p.26}

[04-30-19] - Added Levetiracetam: Oral: 250 mg, 500 mg, 750 mg, and 1 g film coated tablet; Inj.: 500 mg/5 mL (100 mg/mL) concentrate solution for IV infusion, 5 mL vial; Solution:
100 mg/mL oral solution, 100 mL and 300 mL bottle { p.27 }

[04-30-19] - Added Memantine: Oral: 5 mg and 10 mg film coated tablet { p.28 }

[04-30-19] - Added Rifapentine: Oral: 150 mg film coated tablet { p.38 }

[02-22-19] - Added new volume for Paclitaxel ( 6 mg/ml, 16.7 mL IV/IV infusion) { p.34 }

[01-04-19] - Added Epoetin Alfa (Re-inclusion, as per DM No. 2018-0426) : Sterile Solution with 1.5%, 2.3% and 4.25% dextrose, 2 L and 5 L bottle/bag : { p.35 }

2018

[12-18-18] - Added Epoetin Alfa (Re-inclusion, as per DM No. 2018-0418) : 4000 IU/mL solution for injection, 1 mL vial (IV, SC) : { p.17 }

 

In relation to the previously posted schedules of public consultation for the Administrative Order of Health Technology Assessment (HTA), please be advised that only one (1) public consultation will be conducted and the schedule of which will be announced later once finalized.


Kindly disregard the previous schedules posted.


Thank you.